Dimensional Fund Advisors LP Biomarin Pharmaceutical Inc Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,167,495 shares of BMRN stock, worth $66.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,167,495
Previous 1,152,913
1.26%
Holding current value
$66.6 Million
Previous $75.8 Million
8.91%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding BMRN
# of Institutions
669Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.3 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.01 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$853 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$616 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...